Tokyo - Delayed Quote JPY
Sysmex Corporation (6869.T)
2,660.50
+10.50
+(0.40%)
At close: April 25 at 3:30:00 PM GMT+9
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
63,905,000
63,905,000
68,835,000
58,739,000
56,873,000
Investing Cash Flow
-54,970,000
-54,970,000
-51,751,000
-35,052,000
-29,191,000
Financing Cash Flow
-9,013,000
-9,013,000
-24,234,000
-20,542,000
-20,253,000
End Cash Position
75,507,000
75,507,000
69,460,000
73,752,000
66,467,000
Capital Expenditure
-50,191,000
-50,191,000
-42,505,000
-32,034,000
-25,793,000
Issuance of Capital Stock
703,000
703,000
267,000
1,384,000
549,000
Issuance of Debt
29,000,000
29,000,000
--
--
--
Repurchase of Capital Stock
-12,001,000
-12,001,000
--
--
--
Free Cash Flow
13,714,000
13,714,000
26,330,000
26,705,000
31,080,000
3/31/2021 - 1/1/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1EW.MI Edwards Lifesciences Corporation
66.62
+0.86%
BOUL.ST Boule Diagnostics AB (publ)
8.16
+1.96%
EKF.L EKF Diagnostics Holdings plc
21.00
+2.44%
COH.AX Cochlear Limited
264.62
-0.19%
SHL.DE Siemens Healthineers AG
46.84
+2.09%
BIO Bio-Rad Laboratories, Inc.
242.63
-2.85%
EW Edwards Lifesciences Corporation
76.04
+1.21%
SYK Stryker Corporation
365.06
+1.11%